The epidemiology of enterococci

  • C. Chenoweth
  • D. Schaberg
Current Topic: Review

Abstract

The enterococci are emerging as a significant cause of nosocomial infections, accounting for approximately 10 % of hospital acquired infections. They are found as normal inhabitants of the human gastrointestinal tract, but may also colonize the oropharynx, vagina, perineal region and soft tissue wounds of asymtomatic patients. Until recently, evidence indicated that most enterococcal infections arose from patients' own endogenous flora. Recent studies, however, suggest that exogeneous acquisition may occur and that person-to-person spread, probably on the hands of medical personnel, may be a significant mode of transmission of resistant enterococci within the hospital. The use of broad-spectrum antibiotics, especially cephalosporins, is another major factor in the increasing incidence of enterococcal infections. These findings suggest that barrier precautions, as applied with other resistant nosocomial pathogens, along with more judicial use of antibiotics may be beneficial in preventing nosocomial spread of resistant enterococci.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Schlaes DM, Levy J, Wolinsky E: Enterococcal bacteremia without endocarditis. Archives of Internal Medicine 1981, 141:578–581.Google Scholar
  2. 2.
    Hoffman SA, Moellering RC: The enterococcus: “Putting the bug in our ears”. Annals of Internal Medicine 1987, 106: 757–761.Google Scholar
  3. 3.
    Maki DG, Agger WA: Enterococcal bacteremia: clinical features, the risk of endocarditis and management. Medicine 1988, 67: 248–269.Google Scholar
  4. 4.
    Centers for Disease Control; Nosocomial infections surveillance. CDC Surveillance Summaries 1984, 35: 17–29.Google Scholar
  5. 5.
    Whiteside M, Moore J, Ratzan K: An investigation of enterococcal bacteremia. American Journal of Infection Control 1983, 11: 125–129.Google Scholar
  6. 6.
    Morrison AJ, Wenzel RP: Nosocomial urinary tract infections due to enterococcus: ten years's experience at a university hospital. Archives of Internal Medicine 1986, 146: 1549–1551.Google Scholar
  7. 7.
    Gross PA, Harkavy LM, Barden GE, Flower MR: The epidemiology of nosocomial enterococcal urinary tract infection. American Journal of Medical Sciences 1976, 272: 75–81.Google Scholar
  8. 8.
    Kaye D: Enterococci: biologic and epidemiologic characteristics and in vitro susceptibility. Archives of Internal Medicine 1982, 142: 2006–2009.Google Scholar
  9. 9.
    Maki DG: Nosocomial bacteremia: an epidemiologic overview. American Journal of Medicine 1981, 70:719–732.Google Scholar
  10. 10.
    Zervos MJ, Kauffman CA, Therasse PM, Bergman AG, Mikesell TS, Schaberg DR: Nosocomial infection by gentamicin-resistantStreptococcus faecalis: an epidemiologic study. Annals of Internal Medicine 1987, 106: 687–691.Google Scholar
  11. 11.
    Zervos MJ, Dembinski S, Mikesell TS, Schaberg DR: High level resistance to gentamicin inStreptococcus faecalis: risk factors and evidence for exogenous acquisition of infection. Journal of Infectious Disease 1986, 153: 1075–1083.Google Scholar
  12. 12.
    Sherman JM: The streptococci. Bacteriology Reviews 1937, 1: 3–97.Google Scholar
  13. 13.
    Bosley GS, Facklam RR, Grossman D: Rapid identification of enterococci. Journal of Clinical Microbiology 1983, 18: 1275–1277.Google Scholar
  14. 14.
    Jawetz E, Sonne M: Penicillin-streptomycin treatment of enterococcal endocarditis: a re-evaluation. New England Journal of Medicine 1966, 274: 710–715.Google Scholar
  15. 15.
    Moellering RC, Korzeniowski OM, Sande MA, Wennersten CB: Species-specific resistance to antimicrobial synergism inStreptococcus faecium andStreptococcus faecalis. Journal of Infectious Diseases 1979, 140: 203–8.Google Scholar
  16. 16.
    Moellering RC, Wennersten C, Weinberg AN: Synergy of penicillin and gentamicin against enterococci. Journal of Infectious Diseases 1971, 124: 207–209.Google Scholar
  17. 17.
    Toala P, McDonald A, Wilcox C, Finland M: Susceptibility of group D sreptococci (enterococci) to 21 antibiotics in vitro, with special reference to species difference. American Journal of Medical Sciences 1969, 258: 416–430.Google Scholar
  18. 18.
    Fass RJ, Wright CA: Comparative efficacies of mezlocillin and ampicillin alone or in combination with gentamicin in the treatment ofStreptococcus faecalis endocarditis in rabbits. Antimicrobial Agents and Chemotherapy 1984, 25: 408–410.Google Scholar
  19. 19.
    Glew RH, Moellering RC: Effect of protein binding on the activity of penicilin in combination with gentamicin against enterococci. Antimicrobial Agents and Chemotherapy 1979, 15: 87–92.Google Scholar
  20. 20.
    Fass RJ: In vitro activities of β-lactam and aminoglycosides antibiotics: a comparative study of 20 parenterally administered drugs. Archives of Internal Medicine 1980, 140: 766–767.Google Scholar
  21. 21.
    Watanakunakorn C, Glotzbecker C: Comparative in vitro activity of nafcillin, oxacillin and methicillin in combination with gentamicin and tobramycin against enterococci. Antimicrobial Agents and Chemotherapy 1977, 11: 88–91.Google Scholar
  22. 22.
    Weinstein AJ, Moellering RC: Studies of cephalothin: aminoglycoside synergism against enterococci. Antimicrobial Agents and Chemotherapy 1975, 7: 522–529.Google Scholar
  23. 23.
    Simon HJ: Antimicrobial susceptibility of group D hemolytic streptococci (enterococci). American Journal of Medical Sciences 1967, 253: 14–18.Google Scholar
  24. 24.
    Crider SR, Colby SD: Susceptibility of enterococci to trimethoprim and trimethoprim-sulfamethoxazole. Antimicrobial Agents and Chemotherapy 1985, 27: 71–75.Google Scholar
  25. 25.
    Zervos MJ, Schaberg DR: Reversal of in vitro susceptibility of enterococci to trimethoprim-sulfamethoxazole by folinic acid. Antimicrobial Agents and Chemotherapy 1985, 28: 446–448Google Scholar
  26. 26.
    Goodhart GL: In vivo versus in vitro susceptibility of enterococcus to trimetropim-sulfamethoxazole: a pitfall. Journal of the American Medical Association 1984, 252: 2748–2749.Google Scholar
  27. 27.
    Mandell GL, Lindsey E, Hook EW: Synergism of vancomycin and streptomycin for enterococci. American Journal of Medical Sciences 1970, 259: 346–349.Google Scholar
  28. 28.
    Sullam PM, Tauber MG, Hackbarth CJ, Sande MA: Therapeutic efficacy of teicoplanin in experimental enterococcal endocarditis. Antimicrobial Agents and Chemotherapy 1985, 27: 135–136.Google Scholar
  29. 29.
    Mederski-Samoraj BD, Murray BE: High-level resistance to gentamicin in clinical isolates of enterococci. Journal of Infectious Diseases 1983, 147: 751–757.Google Scholar
  30. 30.
    Horodniceanu T, Bouguerleret L, El-Solh N, Bieth G, Debos F: High-level plasmid-born resistance to gentamicin inStreptococcus faecalis subspecieszymogenes. Antimicrobial Agents and Chemotherapy 1979, 16: 686–688.Google Scholar
  31. 31.
    Zervos MJ, Terpenning MS, Schaberg DR, Therasse PM, Medendorp SV, Kauffman CA: High-levelaminoglycoside-resistant enterococci: colonization of nursing home and acute care hospital patients. Archives of Internal Medicine 1987, 147: 1591–1594.Google Scholar
  32. 32.
    Murray BE, Tsao J, Panida J: Enterococci from Bangkok, Thailand, with high level resistance to currently available aminoglycosides. Antimicrobial Agents and Chemotherapy 1983, 23: 799–802.Google Scholar
  33. 33.
    Mundti JD: Enterococci. In: Sneath PH, Mair NS Sharpe ME, Holt JG (ed): Bergey's manual of systematic bacteriology. Williams and Wilkins, Baltimore, 1984, p. 1063–1065.Google Scholar
  34. 34.
    Schleifer KH, Kilpper-Balz R: Transfer ofStreptococcus faecalis andStreptococcus faecium to the genusEnterococcus non rev asenterococcus faecalis comb nov andEnterococcus faecium comb nov. International Journal of Systematic Bacteriology 1984, 34: 31–34.Google Scholar
  35. 35.
    Collins MD, Jones D, Farrow JAE, Killper-Balz R, Schleiffer KH:Enterococcus avium nom rev comb nov;Enterococcus casseliflavus nom rev comb nov;Enterococcus durans nom rev comb nov;Enterococcus gallinarum comb nov; andEnterococcus malodoranus sp. nov. International Journal of Systematic Bacteriology 1984, 34: 220–223.Google Scholar
  36. 36.
    Farrow JAE, Collins MD:Enterococcus hirae a new species that includes amino acid assay strain NCDO 1258 and strains causing growth depression in young chickens. International Journal of Systematic Bacteriology 1985, 35: 73–75.Google Scholar
  37. 37.
    Collins MD, Farrow AE, Jones D:Enterococcus mundtii sp nov. International Journal of Systematic Bacteriology 1986, 36: 8–12.Google Scholar
  38. 38.
    Facklam RR, Collins MD: Identification ofEnterococcus species from human Infectious by a conventional test scheme. Journal of Clinical Microbiology 1989, 27: 731–734.Google Scholar
  39. 39.
    Andrews FW, Harder TJ: A study of the streptococci pathogenic for man. Lancet 1906, ii: 708–713, 775–782.Google Scholar
  40. 40.
    Rantz LA, Kirby WM: Enterococcic infections: an evaluation of the importance of fecal streptococci and related organisms in the causation of human disease. Archives of Internal Medicine 1943, 71: 516–528.Google Scholar
  41. 41.
    Noble CJ: Carriage of group D streptococci in the human bowel. Journal of Clinical Pathology 1978, 31: 1182–1186.Google Scholar
  42. 42.
    Hill MJ, Drasar BS, Aries V, Crowther JS, Hawksworth G, Williams RW: Bacteria and aetiology of cancer of large bowel. Lancet 1971, i: 95–100.Google Scholar
  43. 43.
    Finegold SM, Attebery HR, Sutter VL: Effect of diet on human fectal flora: comparison of Japanese and American diets. American Journal of Clinical Nutrition 1974, 27: 1456–1469.Google Scholar
  44. 44.
    Mead GC: Streptococci in the intestinal flora of man and other nonruminants. In: Skinner FA, Quesnel LB (ed): Streptococci. Academic Press, London, 1978, p. 245–261.Google Scholar
  45. 45.
    Benno Y, Suzuzki K, Narisawa K, Bruce WR, Mitsuoka T: Comparison of fecal microflora in rural Japanese and urban Canadians. Microbiology and Immunology 1986, 30: 521–532.Google Scholar
  46. 46.
    Enzenberger R, Shah PM, Knothe H: Impact of oral ciprofloxacin on the faecal flora of healthy volunteers. Infection 1985, 13: 273–275.Google Scholar
  47. 47.
    Shah PM, Enzenberger R, Glogau O, Knothe H: Influenceof oral ciprofloxacin or ofloxacin on the faecal flora of healthy volunteers. American Journal of Medicine 1987, 82: 333–338.Google Scholar
  48. 48.
    Hardie JM, Marsh PD: Streptococci and the human oral flora. In: Skinner FA, Quesnel LD (ed): Streptococci. Academic press, London, 1978, p. 157–206.Google Scholar
  49. 49.
    Kurrie E, Bhaduri S, Krieger D, Gaus W, Heimpel A, Pfleiger H, Arnold R, Vanek E: Risk factors for infections of the oropharynx and the respiratory tract in patients with acute leukemia. Journal of Infectious Diseases 1981, 144: 128–136.Google Scholar
  50. 50.
    Smyth CJ, Docent MA, Halpenny MK, Ballach SJ: Carriage rates of enterococci in the dental plaque of hemodialysis patients in Dublin. British Journal of Oral and Maxillofacial Surgery 1987, 25: 21–33.Google Scholar
  51. 51.
    Barlett JG, Onderdonk AB, Drude E, Goldstein C, Anderka M, Alpert S, McComack WM: Quantitative bacteriology of the vaginal flora. Journal of Infectious Diseases 1977, 136: 271–277.Google Scholar
  52. 52.
    Tashjian JH, Coulam CB, Washington JA: Vaginal flora in asymptomatic women. Mayo Clinic Proceedings 1976, 51: 557–561.Google Scholar
  53. 53.
    Fukunaga FH: Gallbladder bacteriology, histology and gallstones: study of unselected cholecystectomy specimens in Honolulu. The Archives of Surgery 1973, 106: 169–171.Google Scholar
  54. 54.
    Horvitz RA, von Graevenitz A: A clinical study of the role of enterococci as sole agents of wound and tissue infection. Yale Journal of Biology and Medicine 1977, 50: 391–395.Google Scholar
  55. 55.
    Evans AC, Chinn AL: The enterococci: with special reference to their association with human disease. Journal of Bacteriology 1976, 54: 495–512.Google Scholar
  56. 56.
    Duma RJ, Weinberg AN, Medrek TF, Kunz LJ: Streptococcal infections: a bacteriologic and clinical study of streptococcal bacteremia. Medicine 1969, 48: 87–127.Google Scholar
  57. 57.
    Stamm WE, Weinstein RA, Dixon RE: Comparison of endemic and epidemic nosocomial infection. American Journal of Medicine 1981, 70: 393–397.Google Scholar
  58. 58.
    Hall RW, Bayer AS, Mayer WP, Pitchon HE, Yoslukawa TT, Guze LB: Infective endocarditis following human to human enterococcal transmission: a complication of intravenous narcotic abuse. Archives of Internal Medicine 1976, 136: 1173–1174.Google Scholar
  59. 59.
    Smith RF, Dayton SL: Colonization of burns byStreptococcus faecalis related to contaminated porcine xenografts. Texas Reports on Biology and Medicine 1973, 31: 47–54.Google Scholar
  60. 60.
    Schaberg DR, Zervos M: Plasmid analysis in the study of the epidemiology of nosocomial grampositive cocci. Reviews of Infectious Diseases 1986, 8: 705–711.Google Scholar
  61. 61.
    Zervos MJ, Mikesell TS, Schaberg DR: Heterogeneity of plasmids determining high-level resistance to gentamicin in clinical isolates ofStreptococcus faecalis. Antimicrobial Agents and Chemotherapy 1986, 39: 78–81.Google Scholar
  62. 62.
    Farrar WE: Molecular analysis of plasmids in epidemiologic investigation. Journal of Infectious Disease 1983, 148: 1–6.Google Scholar
  63. 63.
    McGowan JE, Terry PM, Huang T, Hawk CL, Davies J: Nosocomial infections with gentamicin-resistantStaphylococcus aureus: plasmid analysis as an epidemiologic tool. Journal of Infectious Diseases 1979, 140: 864–872.Google Scholar
  64. 64.
    Peacock JE, Marsik FJ, Wenzel RP: Methicillin resistantStaphylococcus aureus: introduction and spread within a hospital. Annals of Internal Medicine 1980, 93: 526–532.Google Scholar
  65. 65.
    Thompson RL, Cabezudo I, Wenzel RP: Epidemiology of nosocomial infections caused by methicillin-resistantStaphylococcus aureus. Annals of Internal Medicine 1982, 97: 309–317.Google Scholar
  66. 66.
    Haley RM, Hightower AW, Khabbaz RF, Thomsberry C, Martone WJ, Allen JR, Hughes JM: Emergence of methicillin resistantStaphylococcus aureus. infections in United States hospitals: possible role of the house staff patient transfer circuit. Annals of Internal Medicine 1982, 97: 297–308.Google Scholar
  67. 67.
    Weinstein RA, Kabins SA: Strategies for prevention and control of multiple drug-resistant nosocomial infection. American Journal of Medicine 1981, 70: 449–454.Google Scholar
  68. 68.
    Coudron PE, Mayhall CG, Kocklam RR, Spadora AC, Lamb VA, Lybrand MR, Dalton HP:Staphylococcus faecium outbreak in a neonatal intensive care unit. Journal of Clinical Microbiology 1984, 20: 1044–1048.Google Scholar
  69. 69.
    Luginbuhl LM, Rotbart HA, Facklam RR, Roe MH, Elliot JA: Neonatal enterococcal sepsis: casecontrol study and description of an outbreak. Pediatric Infectious Disease Journal 1987, 6: 1022–1030.Google Scholar
  70. 70.
    Meers PD, Aylyfe GA, Emmerson AM, Leigh DA, Mayon-White RT, Macintosh CA, Stronge JL: Report on the national survey of infections in hospital 1980. Journal of Hospital Infections 1981, 2: 23–29.Google Scholar
  71. 71.
    Lemoine L, Hunter PR: Enterococcal urinary tract infections in a teaching hospital. European Journal of Clinical Microbiology 1987, 6: 274–275.Google Scholar
  72. 72.
    Warren JW, Tenney JH, Hoopes JM: A prospective microbiologic study of bacteremia in patients with chronic indwelling catheters. Journal of Infectious Diseases 1982, 146:719.Google Scholar
  73. 73.
    McGowan JE, Barnes MW, Finland M: Bacteremia at Boston City Hospital: occurrence and mortality during 12 selected years (1935–1972), with special reference to hospital acquired cases. Journal of Infectious Diseases 1975, 132: 316–335.Google Scholar
  74. 74.
    Garrison RN, Fry DE, Berberich S, Polk HC: Enterococcal bacteremia: clinical implications and determinants of death. Annals of Surgery 1982, 196: 43–47.Google Scholar
  75. 75.
    Malone DA, Wagner RE, Myers JP, Watanakunakorn C: Enterococcal bacteremia in two large community teaching hospitals. American Journal of Medicine 1986, 81: 601–606.Google Scholar
  76. 76.
    Ledger WJ, Norman M, Gee C, Lewis W: Bacteremia on an obstetric-gynecologic service. American Journal of Obstetrics and Gynecology 1975, 121: 205–212.Google Scholar
  77. 77.
    Barrall DT, Kenney PR, Slotman GJ, Burchard KW: Enterococcal bacteremia in surgical patients. Archives of Surgery 1985, 120: 57–63.Google Scholar
  78. 78.
    Dougherty SH, Flohr AB, Simmons RL: Breakthrough enterococcal septicemia in surgical patients: 19 cases and a review of the literature. Archives of Surgery 1983, 118: 232–238.Google Scholar
  79. 79.
    Gibbs RS, Listwa HM, Dreskin RB: A pure enterococcal abscess after cesarean section. Journal of Reproductive Medicine 1977, 19: 17–20.Google Scholar
  80. 80.
    Jones WG, Barie PS, Yuri RW, Goodwin CW: Enterococcal burn sepsis: a highly lethal complication in severely burned patients. Annals of Surgery 1986, 121: 649–653.Google Scholar
  81. 81.
    Siegel JD, McCracken GH: Group D streptococcal infections. Journal of Pediatrics 1978, 93: 542–543.Google Scholar
  82. 82.
    Buchino JJ, Ciamberella E, Light I: Systemic group D streptococcal infection in newborn infants. American Journal of Diseases of Childhood 1979, 133: 270–273.Google Scholar
  83. 83.
    Scheld WM, Mandell GL: Enigmatic enterococcal endocarditis. Annals of Internal Medicine 1984, 100: 904–905.Google Scholar
  84. 84.
    Teixeira OH, Carpenter B, Vald P: Enterococcal endocarditis in early infancy. Canadian Medical Association Journal 1982, 127: 612–613.Google Scholar
  85. 85.
    Zakrzewski T, Keith JD: Bacterial endocarditis in infants and children. Journal of Pediatrics 1965, 67: 1179–1193.Google Scholar
  86. 86.
    Koenig MG, Kaye D: Enterococcal endocarditis report of nineteen cases with long term follow up data. New England Journal of Medicine 1961, 264: 257–264.Google Scholar
  87. 87.
    Mandell GL, Kaye D, Levison ME, Hook EW: Enterococcal endocarditis: an analysis of 38 patients observed at the New York Hospital-Cornell Medical Center. Archives of Internal Medicine 1970, 125: 258–264.Google Scholar
  88. 88.
    Wilson WR, Wilkowski CJ, Wright AJ, Sande MA, Geraci JE: Treatment of streptomycin-susceptible and streptomycin-resistant enterococcal endocarditis. Annals of Internal Medicine 1984, 100: 816–823.Google Scholar
  89. 89.
    Rigilano J, Mahapatra R, Barnhill J, Gutierrez J: Enterococal endocarditis following sigmoidoscopy and mitral valve prolapse. Archives of Internal Medicine 1984, 144: 850–851.Google Scholar
  90. 90.
    Moellering RC, Watson BK, Kunz LJ: Endocarditis due to group D streptococci: comparison of diseases caused byStreptococcus bovis with that produced by the enterococci. American Journal of Medicine 1974, 57: 239–250.Google Scholar
  91. 91.
    Reiner NE, Gopalakrishna KV, Lerner PI: Enterococcal endocarditis in heroin addicts. Journal of the American Medical Association 1976, 235: 1861–1863.Google Scholar
  92. 92.
    Dougherty SH: Role of enterococcus in intra abdominal sepsis. American Journal of Surgery 1984, 148: 308–312.Google Scholar
  93. 93.
    Onderdonk AB, Bartlett JG, Louie TJ, Sullivan-Seigler N, Gorbach SL: Microbial synergy in experimental intra-abdominal abscess. Infection and Immunity 1976, 13: 22–26.Google Scholar
  94. 94.
    Fass RJ: Treatment of mixed bacterial infections with clindamycin and gentamicin. Journal of Infectious Diseases 1977, 135: 74–79.Google Scholar
  95. 95.
    Canadian Metronidazole Study Group: Prospective, randomized comparison of metronidazole and clindamycin, each with gentamicin for the treatment of serious intra-abdominal infection. Surgery 1983, 93: 221–229.Google Scholar
  96. 96.
    Zervos MJ, Bacon AE, Patterson JE, Schaberg DR, Kauffman CA: Enterococcal superinfection in patients treated with ciprofloxacin. Journal of Antimicrobial Chemotherapy 1988, 21: 113–115.Google Scholar
  97. 97.
    Curry N, McCallum RW, Guth PH: Spontaneous peritonitis in cirrhotic ascites: a decade of experience. American Journal of Digestive Diseases 1974, 19: 685–692.Google Scholar
  98. 98.
    Leigh DA: Peritoneal infections in long term peritoneal dialysis before and after human cadaveric tranplanation. Journal of Clinical Pathology 1969, 22: 539–544.Google Scholar
  99. 99.
    Bayer AS, Seidel JS, Yoshikawa TT, Anthony BF, Guze LB: Group D enterococcal meningitis: clinical and therapeutic considerations with report of three cases and review of the literature. Archives of Internal Medicine 1976, 136: 883–886.Google Scholar
  100. 100.
    Schoenbaum SC, Gardner P, Shillito J: Infections of cerebrospinal fluid shunts: epidemiology, clinical manifestations and therapy. Journal of Infectious Diseases 1975, 131: 543–552.Google Scholar
  101. 101.
    Ryan JL, Pachner A, Andriole VT, Root RK: Enterococcal meningitis: combined vancomycin and rifampin therapy. American Journal of Medicine 1980, 68: 449–451.Google Scholar
  102. 102.
    Berk SL, Verghese A, Holtsclaw SA, Smith JK: Enterococcal pneumonia: occurrence in patients receiving broad-spectrum antibiotic regimens and enteral feeding. American Journal of Medicine 1983, 74: 153–154.Google Scholar
  103. 103.
    Feeley TW, DuMoulin GC, Hedley-White J, Bushnell LS, Gilbert JP, Feingold DS: Aerosol polymixin and pneumonia in seriously ill patients. New England Journal of Medicine 1975, 293: 471–475.Google Scholar

Copyright information

© Friedr. Vieweg & Sohn Verlagsgesellschaft mbH 1990

Authors and Affiliations

  • C. Chenoweth
    • 1
  • D. Schaberg
    • 1
  1. 1.Department of MedicineDivision of Infectious Diseases University of Michigan Medical SchoolAnn ArborUSA

Personalised recommendations